Life Sciences

Virtual clinical trials

Huma's virtual clinical trial solution connects trial participants, investigators, and research teams. It accelerates recruitment while driving participant engagement and protocol adherence. Huma’s ​technology for clinical trials​ reduces participant burden and improves the visibility of patient-generated data collected in the real-life setting.

The Current Situation

The unmet need in virtual
clinical trials

One of the most important parts of clinical research is the patient’s ability to participate. By making research more human-centric and giving participants the ability to virtually access and actively engage in trials, we can lower the burden on participants, and increase engagement and retention rates.

man in armchair using mobile app

80%

of sites fail to enroll the target
number of participants 1

30%

of trials are canceled
due to
insufficient
participation 3

40%

of long-term trial participants stop
taking their medication after one year 5

23%

of participants are dissatisfied
with site location 2

30%

of participant drop out
before the
study ends 4

Our offering

How our virtual
clinical trial
solution
can help you

screen app showing patient data screen app showing patient data
Integrated devices

We have integrated a portfolio of over 400 external wearables and connected devices to enable seamless data capture. We have established partnerships with device distributors.

Site dashboard

A web-based dashboard providing insight into participant data generated from the patient app. Allows remote monitoring of participants through their provided device data/PROMs, and incorporates telemedicine for direct communication with participants.

Patient app

Device-agnostic app that enables remote participant data capture, and houses educational content for improved participant engagement. Huma's app can be configured from a portfolio of 100+ modules to meet the needs of your clinical trial protocol.

Our offering

How our virtual
clinical trial
solution
can help you

participants and carers
Participants/Carer

Engaging device-agnostic app:

Remotely collects data, reducing the number of site visits, and lowering the burden on participants and their families.

Guides patients on using medication, and provides reminders on when to take/record medication use at home.

Delivers high protocol adherence, helping participants/carers know what is expected of them and when.

Includes integrated sensors and can connect to 400+ devices.

investigator
Investigator/HCP

Remote data monitoring platform:

Provides real-time visibility of patient data.

Includes telemedicine for easy communication with participants/patients for remote visits/assessments.

Provides alerts & thresholds to help easily identify patients that require support or urgent follow-up.

Visualises individual patient adherence to study schedule.

sponsor
Sponsor

Remote study monitoring platform:

Improves adherence to clinical trial protocols, reducing missing data.

Improves participant engagement and retention, reducing drop out rates.

Provides visibility of usability metrics, identifying those participants that require the most support.

Provides access to de-identified and structured data.

Cloud agnostic, rapidly deployable, modular solution.

Participants/Carer

Engaging device-agnostic app:

Remotely collects data, reducing the number of site visits, and lowering the burden on participants and their families.

Guides patients on using medication, and provides reminders on when to take/record medication use at home.

Delivers high protocol adherence, helping participants/carers know what is expected of them and when.

Includes integrated sensors and can connect to 400+ devices.

Investigator/HCP

Remote data monitoring platform:

Provides real-time visibility of patient data.

Includes telemedicine for easy communication with participants/patients for remote visits/assessments.

Provides alerts & thresholds to help easily identify patients that require support or urgent follow-up.

Visualises individual patient adherence to study schedule.

Sponsor

Remote study monitoring platform:

Improves adherence to clinical trial protocols, reducing missing data.

Improves participant engagement and retention, reducing drop out rates.

Provides visibility of usability metrics, identifying those participants that require the most support.

Provides access to de-identified and structured data.

Cloud agnostic, rapidly deployable, modular solution.

  • Participants/Carer
  • Investigator/HCP
  • Sponsor

How it works

How does our app support
participants during clinical trials?

Pre-screening

Enables sponsors to access a wider population, and pre-screen patients to identify those likely to meet the study eligibility criteria, reducing screen failure rates.

Schedule

In-app reminders and key actions ensure participants know what is expected of them and when, which improves protocol compliance and reducing missed visits.

Remote visits

Huma’s telemedicine solution enables investigators to promptly support participants remotely, reducing clinical site visits and improving the participant experience.

Educational Content

Targeted information, ensuring clear expectations are communicated at the start, and patients are supported at every milestone and feel valued with regular study updates.

e-Consent

In-built e-consent functionality, that supports remote on-boarding and allows patients to be fully informed prior to trial initiation
(Coming soon).

Medication tracker

Guides participants on using medication, and provides reminders on when to take/record medication use at home or return to the clinic for their treatment.

Data collection

Huma has an extensive library of core and 3rd-party modules to track and monitor participants e.g. ePROs, eDiary, ePerfOs, activity tracking.

Device integration

Device agnostic with the ability to capture data from 400+ connected devices, wearables, and phone sensors

  • Pre-screening
  • e-Consent
  • Schedule
  • Medication tracker
  • Remote visits
  • Data collection
  • Educational Content
  • Device integration

Enables sponsors to access a wider population, and pre-screen patients to identify those likely to meet the study eligibility criteria, reducing screen failure rates.

In-built e-consent functionality, that supports remote on-boarding and allows patients to be fully informed prior to trial initiation
(Coming soon).

In-app reminders and key actions ensure participants know what is expected of them and when, which improves protocol compliance and reducing missed visits.

Guides participants on using medication, and provides reminders on when to take/record medication use at home or return to the clinic for their treatment.

Huma’s telemedicine solution enables investigators to promptly support participants remotely, reducing clinical site visits and improving the participant experience.

Huma has an extensive library of core and 3rd-party modules to track and monitor participants e.g. ePROs, eDiary, ePerfOs, activity tracking.

Targeted information, ensuring clear expectations are communicated at the start, and patients are supported at every milestone and feel valued with regular study updates.

Device agnostic with the ability to capture data from 400+ connected devices, wearables, and phone sensors

How it works

How does our solution support investigators and research teams

laptop demo of patient generated data
Real-life data collection

A comprehensive platform to collect high frequency everyday health data from sensors, devices and questionnaires.

Integrate and Combine

One of the benefits of virtual clinical trials is the​ integration with EDC systems to combine real-life data with other clinical trial data.

Insights and analytics

Remote data visualised in a customisable dashboard, enabling real-time interrogation and analysis of data to discover insights.

laptop demo of patient generated data

Why Huma?

Core benefits

trusted partner
Trusted Partner

Medical device grade platform built under a Quality Management System compliant with global security, privacy and regulatory requirements.

experienced
Experienced

Deployments with top 10 pharma companies, national governments, major healthcare providers and leading research institutions.

globally deployable
Globally Deployable

Cloud agnostic platform that is ready to be deployed on any infrastructure and in any language.

integration
Integration

Our platform and captured data can be efficiently transferred and integrated with other clinical data sources, and platforms.

device agnostic
Device Agnostic

Digital biomarker solutions available on both iOS and Android, and can integrate and gather data from 400+ wearables devices.

high patient adherence
High Patient Adherence

Engaging experience for patients and trial participants, achieving high adherence rates.

250,000 modules already completed by participants so far.

actionable insights
Actionable Insights

Customisable dashboards provide real-time insights that help proactively monitor patients, manage patient care, and improve adherence.

Trusted Partner

Medical device grade platform built under a Quality Management System compliant with global security, privacy and regulatory requirements.

Experienced

Deployments with top 10 pharma companies, national governments, major healthcare providers and leading research institutions.

Globally Deployable

Cloud agnostic platform that is ready to be deployed on any infrastructure and in any language.

Integration

Our platform and captured data can be efficiently transferred and integrated with other clinical data sources, and platforms.

Device Agnostic

Digital biomarker solutions available on both iOS and Android, and can integrate and gather data from 400+ wearables devices.

High Patient Adherence

Engaging experience for patients and trial participants, achieving high adherence rates.

250,000 modules already completed by participants so far.

Actionable Insights

Customisable dashboards provide real-time insights that help proactively monitor patients, manage patient care, and improve adherence.å

  • Trusted Partner
  • Experienced
  • Globally Deployable
  • Integration
  • Device Agnostic
  • High Patient Adherence
  • Actionable Insights

Why Huma

An opportunity to
have a direct

relationship with the
patient

why huma why huma

Our platform gives life science companies the opportunity to build a longitudinal relationship with a patient population.

From sending out updates to participants who have been involved in studies (e.g. published results and regulatory approvals), to staying in contact with participants for follow-up studies (e.g. market research and RWE studies), Huma's ​preventative health and​ digital solutions make research more human-centric.

case study 1

Recruited several thousand
participants within weeks

Case study

Powering one of
the largest
virtual
clinical studies with

Cambridge University

Huma partnered with the longitudinal Fenland cohort study and the Medical Research Council (MRC) Epidemiology Unit, University of Cambridge to understand the progression of and build early predictive models of presymptomatic COVID-19 infection.

The study involves 12,435 participants, with 15 years of existing data. The aim of the collaboration is to create a joint analytics dataset for digital biomarker discovery.

Case study

Supporting a virtual
clinical
trial in Atrial
Fibrillation

Huma is currently working with Bayer, Stanford Medicine and the Stanford Center for Digital Health (CDH) to validate an approach to decentralise the clinical trial experience for patient participants with atrial fibrillation. The study aims to prove the feasibility, acceptability, and best practices that can achieve high compliance, quality, and scientifically sound fully remote clinical trials.

This 6-month Decentralised Clinical Trial (DCT) will utilise Huma’s remote data collection platform to monitor medication adherence, conduct remote surveys and televisits, send information and reminders to patients, and track key disease symptoms by connecting to electrocardiogram (ECG) and blood pressure (BP) devices.

case study 2

Went live with the first participant
recruited in less than 5 weeks

This field is required

This field is required

This field is required

This field is required

This field is required

Huma is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

By clicking submit below, you consent to allow Huma to store and process the personal information submitted above to provide you the content requested.

thumbs up
One of our team members will be in touch with you shortly.
There was an error submitting your form. Please refresh and try again.

Sources
1.

Clinical trial delays: America’s patient recruitment dilemma. (2012) https://www.clinicaltrialsarena.com/analysis/featureclinical-trial-patient-recruitment/

2.

Perceptions & Insights Study: The Participation Decision-Making Process. The Center for Information and Study on Clinical Research Participation (CISCRP) (2017) https://www.ciscrp.org/wp-content/uploads/2019/06/2017-CISCRP-Perceptions-and-Insights-Study-Decision-Making-Process.pdf

3.

Why clinical trials are terminated. Pak, Theodore R., Rodriguez, Maria D., Roth, Frederick P. biorxiv.org/content/10.1101/021543v1

4.

Differential dropout and bias in randomised controlled trials: when it matters and when it may not. Bell, Melanie L., Kenward, Michael G., Fairclough, Diane L., and Horton, Nicholas J. (2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688419/

5.

Smart Medication Adherence Monitoring in Clinical Drug Trials: A Prerequisite for Personalised Medicine? NCBI. Zijp, Tanja R., Mol, Peter G.M., Touw, Daan J., and van Boven, Job F.M. (2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833361/